Intervention1: Dexamethasone ophthalmic suspension (OCS-01): The interventional drug OCS-01 eye drops will be dispensed in single dose containers for each subject to have enough medication until the n

2 trials

Sponsors

Oculis Operations Sàrl

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Phase 2

Study of the efficacy and safety of OCS-01 eye drops in subjects with diabetic macular edema (DIAMOND-1).

Active, not recruitingCTRI/2024/07/070816

Oculis Operations SàrlHealth Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Target: 350Updated: 2024-07-22

Phase 3

Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema. (DIAMOND-2)

Active, not recruitingCTRI/2024/07/071429

Oculis Operations SàrlHealth Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Target: 350Updated: 2024-08-19